Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.
about
Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysisTransmission of Tropical and Geographically Restricted Infections during Solid-Organ TransplantationLeishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeterPrevalence of transfusion-transmitted Chagas Disease among multitransfused patients in Brazil.Trypanosoma cruzi: seroprevalence detected in the blood bank of the Instituto Nacional de Pediatría, Mexico City, in the period 2004 through 2009.Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.Arboprotozoae.Seroprevalence of Chagas infection in the donor population.Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment.A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico.Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study).Transmission of Chagas disease via blood transfusions in 2 immunosuppressed pigtailed macaques (Macaca nemestrina)Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission.Novel drug discovery for Chagas disease.Blood system changes since recognition of transfusion-associated AIDS.Frequency of Trypanosoma cruzi parasitemia among infected blood donors with a potential association between parasite lineage and transfusion transmission.Interleukin-17, oxidative stress, and inflammation: role of melatonin during Trypanosoma cruzi infection.Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.Bioluminescent imaging of Trypanosoma cruzi infection.Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi.Lessons learned from Trypanosoma cruzi test implementation.Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico.Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening.Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.
P2860
Q26774182-5AABA939-5140-4CF5-B114-728BB9A69D18Q27485255-A09CD8D2-5949-4EFE-9DC0-58EFAC3CEF7EQ30423076-17AB8A27-796B-4F7B-B85F-369C4BEC94ACQ33315035-7E76EAFD-E7D9-4342-8233-5E1C697BE1ACQ33453952-54ADBF8B-B401-4651-8628-E8BB910AF12BQ33604028-DFFE82FD-5BE9-4F3A-B498-A22A401A412EQ33756086-6BA5F6AC-E19D-411A-9FDE-79F71744B5C5Q34086340-D419E7A9-5531-445C-BF0E-B98E3BABAA97Q34364999-FAB0089F-BAAD-4434-8E2E-7BA83D0236BAQ34968549-0B42E4D7-85D3-425A-9F20-CEF29ABF7215Q35914219-9C053943-D3C6-4140-B92B-207B7E6F62CEQ35965823-F738F0C9-2F20-4F40-B984-6F3FB9AD6C34Q36097130-3F1741D0-ED98-461F-925B-D4B2C5FF5232Q37045828-7003F95D-A121-4E92-B0B3-6EBCB10FA8B8Q37466869-D62E33E6-12D7-41BE-BF8E-2BAAE0EBCBDAQ37593309-754C27E6-401A-451F-BAEA-71ACF63DCB86Q37982844-59634280-64C1-463E-B3A2-BB19019E7A63Q38770142-B3F20426-0FEB-48BB-8576-534B8B6BB57BQ40234714-D64864C7-F920-4C17-A558-175FE3AA8FC6Q40293612-EF1D6805-B97D-4056-9109-18980A38BD7CQ40968042-F2178918-E4FB-4713-B506-B59AA3BF7D67Q41744735-50433363-AF31-45A6-9039-ABA4EF6D9ECFQ41760091-BCCA99B6-1AB1-45AB-9B82-ECD0483548DFQ41811516-20F42E2F-A98D-482F-A96D-883C2D4C2B5DQ43427307-EEA74A8F-A7D6-44C2-93E7-339E2C374581Q43508320-8D03DA86-759D-45CB-ADDE-E71BA51CB28EQ46187530-97D25078-C131-46D9-9A75-C5FD3754F709Q46859893-8E4C3734-6C37-4FBF-BB98-84127641D942Q53588078-F982F462-0AF9-476C-8DC1-03F71097A2AC
P2860
Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Transfusion-associated Chagas ...... medicine in the United States.
@en
Transfusion-associated Chagas disease
@nl
type
label
Transfusion-associated Chagas ...... medicine in the United States.
@en
Transfusion-associated Chagas disease
@nl
prefLabel
Transfusion-associated Chagas ...... medicine in the United States.
@en
Transfusion-associated Chagas disease
@nl
P2093
P2860
P1433
P1476
Transfusion-associated Chagas ...... medicine in the United States.
@en
P2093
Abel Lomelí-Guerrero
Carlos S Ron-Guerrero
José G Peña-Muñoz
Louis V Kirchhoff
Manuel Delgado-Mejía
Mario Paredes-Espinoza
Patricia Paredes
P2860
P304
P356
10.1111/J.1537-2995.2006.00715.X
P577
2006-02-01T00:00:00Z